Chemoablation for Low-Grade Bladder Cancer

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 27, 2023

Primary Completion Date

November 30, 2027

Study Completion Date

November 30, 2027

Conditions

Bladder (Urothelial, Transitional Cell) Cancer

Interventions

DRUG

Gemcitabine

Intravesical installation

Trial Locations (1)

RECRUITING

Department of Urology, Medical University of Vienna, Vienna

All Listed Sponsors

lead

Ekaterina Laukhtina

OTHER